Progress of chimeric antigen receptor T-cell therapy in treatment of hematological malignancies
10.3760/cma.j.issn.1009-9921.2019.12.000
- VernacularTitle:嵌合抗原受体T细胞疗法在恶性血液病治疗中的研究进展
- Author:
Huanying REN
1
;
Xiuhua CHEN
;
Jing XU
;
Hongwei WANG
Author Information
1. 山西医科大学第二医院血液病研究所 血液病分子诊疗山西省重点实验室，太原 030001
- From:
Journal of Leukemia & Lymphoma
2020;29(5):310-312
- CountryChina
- Language:Chinese
-
Abstract:
Chimeric antigen receptor T-cell (CAR-T) therapy is effective in treating lymphoma and leukemia. A large number of basic and clinical studies have led to the rapid development of CAR-T therapy. This paper reviews the concept of CAR-T therapy, the application of CAR-T in hematologic diseases, and the problems and solutions of CAR-T.
